×
戻る Agenda
Session 6: Key Outstanding Issues to be Resolved
Session Chair(s)
Virginia Acha, PHD, MSC
Global Lead, Global Regulatory Policy
Merck, United States
Speaker(s)
Esteban Herrero-Martinez, PHD
Novartis Pharmaceuticals UK Limited, United Kingdom
Director Regulatory Policy and Intelligence
Charles-Albert Helleputte
Mayer Brown Europe, Belgium